Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions.
Fang AM, Shumaker LA, Martin KD, Jackson JC, Fan RE, Khajir G, Patel HD, Soodana-Prakash N, Vourganti S, Filson CP, Sonn GA, Sprenkle PC, Gupta GN, Punnen S, Rais-Bahrami S.
Fang AM, et al. Among authors: martin kd.
Cancer. 2022 Sep 15;128(18):3287-3296. doi: 10.1002/cncr.34355. Epub 2022 Jul 12.
Cancer. 2022.
PMID: 35819253
Free article.